Adoption of Pharmaceutical Trademarks for Approval: Navigating Differing Standards at the FDA and USPTO
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE course will guide IP counsel on the complexities of the pharmaceutical trademark adoption process to support a successful launch of a company's new pharmaceutical product. In particular, the panel will discuss the challenges inherent in pharmaceutical brand development and approval, an overview of the pharmaceutical trademark adoption process from brainstorming to clearance, as well as the FDA trademark review process, and best practices to minimize the risk of rejection.
- Challenges to pharmaceutical trademark development and approval
- Differing approaches to trademark review by the USPTO and the FDA
- Overview of the pharmaceutical trademark adoption process
- Overview of the FDA trademark review process
- Best practices for adopting and clearing pharmaceutical trademarks and reducing the risk of rejection
The panel will review these and other priority issues:
- What unique challenges do pharmaceutical companies face in seeking to adopt trademarks for pharmaceuticals and biologics?
- What are the differences between the FDA trademark review process and the USPTO trademark review process, why, and what are the consequences?
- What best practices should companies employ for adopting and clearing pharmaceutical trademarks?
Ilene B. Tannen
Ms. Tannen specializes in trademark and copyright law and practices in the firm’s global Trademarks, Unfair... | Read More
Ms. Tannen specializes in trademark and copyright law and practices in the firm’s global Trademarks, Unfair Competition & Copyrights Group. She is also a former member of the Trademark Public Advisory Committee (TPAC) of the United States Patent and Trademark Office. Ms. Tannen manages global trademark portfolios for domestic and multinational companies, advising on clearance, brand development and use, registration strategies, and enforcement, in such industries as pharmaceuticals, telecommunications, apparel, sports, food and beverages, and financial services. She also counsels companies regarding the use of their intellectual property in online content and social media and advises clients regarding copyright protection and use. Ilene is the author of the U.S. Chapter in Thomson Reuters’ well-regarded, go-to trademark resource Trademarks Throughout the World, Fifth Edition, wherein she addresses trademark registration practice and procedures under U.S. trademark law.Close
Creative Brand Institute
Mr. Piergrossi serves as executive creative director for the company’s global brand naming projects and is... | Read More
Mr. Piergrossi serves as executive creative director for the company’s global brand naming projects and is responsible for the creative strategy and methodology used in name development. He has led thousands of brand naming projects during his 18 years with Brand Institute, primarily for pharmaceutical products and medical devices, clinical trials, line extensions/modifiers, companies, and consumer products. He is proficient in the disciplines related to the creation and marketing of brands, including strategy, positioning, trademark law, and regulatory affairs. As President, Operations & Communications, he led Brand Institute’s Miami-based operations and global corporate communications in his previous role as President. He continues to be head of corporate communications and media relations. He has appeared on/been quoted in various national/international print, radio, online, and television media, including CNN, CNBC, Bloomberg, CBS News Sunday Morning, NPR, STAT, Reuters, and the Miami Herald, among others.Close
Early Discount (through 10/01/21)
Cannot Attend October 26?
Early Discount (through 10/01/21)
You may pre-order a recording to listen at your convenience. Recordings are available 48 hours after the webinar. Strafford will process CLE credit for one person on each recording. All formats include course handouts.